Xeraya Capital

Xeraya Capital

Xeraya Capital, a independent operation of the Malaysia sovereign wealth fund, is a venture capital and private equity firm investing in the life sciences industry.

Xeraya Capital is a venture capital and private equity firm headquartered in Kuala Lumpur, Malaysia. It was founded it 2012 by the Khazanah Nasional Berhad, the sovereign wealth fund of the Malaysia. The firm invests in the life sciences industry. It has invested in medical technologies, biotechnology, pharmaceuticals, and biorenewable fuel resources.

In 2018, Xeraya Capital signed the United Nations sponsored Principals for Responsible Investment, which aims to create a more sustainable global financial system. The firm as a whole aims to improve the lives of Southeast Asians and humanity through its investing.

Timeline

Funded Companies

Company
Description
Industry
Website
Location
Gevo, Inc

A renewable chemicals and advanced biofuels company.

A pharmaceutical company developing tissue factor therapies for the treatment of cancer and diseases.

Gevo is an Englewood, California-based producer of biofuels and cost-effective fossil fuel alternatives.

A bio-renewable chemistry company developing and producing specialty chemicals using renewable feedstocks

Congenica clinical decision support software is the world's leading solution for the analysis of genomic data, enabling healthcare professionals globally

6 Results
Results per page:
Page 1 of 1

People

Name
Role
LinkedIn

Further reading

Title
Author
Link
Type
Date

Documentaries, videos and podcasts

Title
Date
Link

Companies

Company
CEO
Location
Products/Services

News

Title
Author
Date
Publisher
Description
Yimie Yong
November 19, 2020
DealStreetAsia
Last week, Xeraya announced its participation in Congenica's Series C round.
Yimie Yong
November 11, 2020
DealStreetAsia
The round was co-led by Legal & General (UK) and Tencent (China).
Golden logo
Text is available under the Creative Commons Attribution-ShareAlike 4.0; additional terms apply. By using this site, you agree to our Terms & Conditions.